Viewing Study NCT04931784



Ignite Creation Date: 2024-05-06 @ 4:16 PM
Last Modification Date: 2024-10-26 @ 2:07 PM
Study NCT ID: NCT04931784
Status: UNKNOWN
Last Update Posted: 2021-06-18
First Post: 2021-06-07

Brief Title: Effect of Ultimaster Stents Treated to the Most Dilated Coronary Vessels
Sponsor: Inha University Hospital
Organization: Inha University Hospital

Study Overview

Official Title: Prospective Open Randomized Study Comparing the Effects of Ultimaster Stents Treated With Conventional Methods on Coronary Artery Lesions Compared to the Most Dilated Coronary Vessels
Status: UNKNOWN
Status Verified Date: 2021-06
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In patients with vasospasm or with negative remodeling various vasodilator drugs used during coronary angiography can dilate the diameter of the reference vessel to measure the exact vessel size In particular nitrates are well known to induce pharmacological vasodilatory effects through vascular smooth muscle relaxation In actual clinical practice it has been reported that when oral or spray-type nitrate preparations are administered to coronary artery stenosis lesions the diameter of the reference vessel expands by about 10 compared to the existing vessel diameter This may enable larger stenting in coronary artery stenosis lesions Although many patients with vascular stenosis are accompanied by vasospasm and voice remodeling in actual clinical practice administration of vasodilators is only used in a small number of patients at the discretion of the surgeon Nitrate vasodilators administered during coronary angiography are low-dose and short-acting drugs and although a small number of patients may experience side effects such as short-term lowering of blood pressure no serious side effects are reported

On this background this study is to evaluate whether there is a difference in the diameter of the Ultimaster stent treated with the conventional method compared to the maximally dilated coronary artery and to evaluate the stability and effectiveness after the procedure
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None